TrialAge and ageing2026

A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results.

Federica Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.